New pathway cuts red tape and brings predictability to Medicare coverage for Breakthrough DevicesContinue reading
Category Archives: Advocacy and Regulations
Jake Birecki Makes Space for Passion, Purpose and Play
AZBio Members are driven by their commitment to improve the lives of patients and their families. At BioMarin, part of this commitment includes sharing the stories of the people they work to serve. In the first edition of their “Making Space” series, BioMarin profiled Arizona-native Jake Birecki.Continue reading
Learn About the 2026 Arizona Primary Election and Candidates
Arizonans can now see who has gathered the required number of signatures to appear on the 2026 Arizona Primary Ballot.
Arizona.Vote is the official source for Primary Election and General Election information in Arizona. The 2026 Primary Election is July 21, 2026. Early voting begins on June 24, 2026.
Senate Passes SBIR Reauthorization
On Tuesday, March 3, 2026, the Senate Unanimously Passed the Senate Bill 3971, the Small Business Innovation and Economic Security Act, that would extend the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through Sept. 30, 2031. The measure now moves to the U.S. House of Representatives for final approval. Continue reading
AZ House HHS Testimony Supporting the Arizona Health Innovation Trust Fund
HB 2727: appropriations; health innovation trust fund is sponsored by Representative Selina Bliss, Chairman of the Arizona House of Representatives Health and Human Services Committee (H-HHS) and co-chair of the Arizona Bioscience and Healthcare Caucus. House Bill 2727 was heard in H-HHS on February 2, 2026. The bill passed out of committee with a Do Pass recommendation on a vote of Continue reading
Chairman Cassidy Releases Landmark Report to Modernize FDA, Deliver Lifesaving, Affordable Treatments to American Families
WASHINGTON – U.S. Senator Bill Cassidy, M.D. (R-LA), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a landmark report detailing legislative and regulatory reforms to modernize the Food and Drug Administration (FDA). These proposals aim to maintain American biomedical dominance and ensure patients have timely access to the latest lifesaving treatments. The HELP Committee’s recommendations are directly in line with President Trump’s mission to improve the health of American children and families.Continue reading
New Health Policy Included Federal Government Funding Package
When President Trump signed H.R. 7148, the Consolidated Appropriations Act, 2026, it did more than end the four-day partial shutdown. The Act also includes a number of reauthorizations and new policies that have been advocated by patients, healthcare professions, and innovative healthcare companies. Continue reading
Long Awaited Legislation on Multi Cancer Early Detection Tests for Medicare Beneficiaries Becomes Law
On February 3, 2026, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act was signed into law, establishing Medicare coverage for blood-based Multi-Cancer Early Detection (MCED) tests. Continue reading
Tracking U.S. Biopharma Investment: New Resources Detail State-by-State Impact
America’s biopharmaceutical sector is delivering unprecedented economic impact across the nation. Since January 2025, companies have committed more than $582 billion to bolster U.S. research and development, expand manufacturing and create jobs in communities nationwide.From cutting-edge manufacturing facilities in the South to next-generation research hubs in the Mid-Atlantic, the life sciences industry is driving local economic growth, creating high-skill jobs and ensuring Americans have faster access to breakthrough medicines.Continue reading